The PE Ratio as of December 2025 (TTM) for NextCell Pharma AB (NXTCL.ST) is -1.58

According to NextCell Pharma AB’s latest financial reports and current stock price. The company's current PE Ratio is -1.58. This represents a change of -63.97% compared to the average of -4.38 of the last 4 quarters.

NextCell Pharma AB (NXTCL.ST) Historical PE Ratio (quarterly & annually)

How has NXTCL.ST PE Ratio performed in the past?

The mean historical PE Ratio of NextCell Pharma AB over the last ten years is -9.68. The current -1.58 PE Ratio has changed 1.53% with respect to the historical average. Over the past ten years (40 quarters), NXTCL.ST's PE Ratio was at its highest in in the August 2017 quarter at -0.71. The PE Ratio was at its lowest in in the August 2021 quarter at -55.66.

NextCell Pharma AB (NXTCL.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NextCell Pharma AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NextCell Pharma AB (NXTCL.ST) Average PE Ratio

How has NXTCL.ST PE Ratio performed in the past?

The current PE Ratio of NextCell Pharma AB (NXTCL.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NextCell Pharma AB (NXTCL.ST) PE Ratio vs. Peers

How is NXTCL.ST’s PE Ratio compared to its peers?

NextCell Pharma AB’s PE Ratio is greater than Active Biotech AB (publ) (-1.93), greater than Pila Pharma AB (publ) (-5.49), less than Biovica International AB (publ) (-0.60), less than Nanologica AB (publ) (-1.42), greater than Biosergen AB (-3.66), greater than Sprint Bioscience AB (publ) (-6.01), greater than Scandinavian ChemoTech AB (publ) (-10.01), less than Immunovia AB (publ) (-0.58), greater than Iconovo AB (publ) (-1.59), greater than Spago Nanomedical AB (publ) (-1.78),

Build a custom stock screener for NextCell Pharma AB (NXTCL.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCell Pharma AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NextCell Pharma AB (NXTCL.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NextCell Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.